This website is intended for the use of shareholders and investors. The "Investors" contents are created and published to provide information on the Company s. | May 10, 2023
Kyowa Kirin Announces Phase III Study Results of bardoxolone methyl in Japan and Discontinuation of Development Tokyo, Japan, May 10, 2023 Kyowa Kirin Co.,. | May 10, 2023
Kyowa Kirin Co., Ltd. hereby announces that Kyowa Kirin International plc, a subsidiary of the Company, has signed a Joint Venture Collaboration agreement with Grunenthal GmbH for the established. | November 25, 2022